Trial Profile

MDMA-assisted Therapy in Twelve People With War and Terrorism-related Posttraumatic Stress Disorder (PTSD)

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 29 Jan 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Methylenedioxymetamfetamine (Primary)
Indications Post-traumatic stress disorders
Focus Therapeutic Use
Acronyms MP-3
Sponsors Lykos Therapeutics

Most Recent Events

01 Apr 2011 Status changed from active, no longer recruiting to discontinued, according to ClinicalTrials.gov.
19 Jul 2010 Integrated additional information from the Multidisciplinary Association for Psychedelic Studies website.
22 Sep 2009 Planned end date changed from 1 Apr 2009 to 1 Dec 2010 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com